Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding trial of Yuping Tongqiao Tablets for persistent allergic rhinitis
ChiCTR2100042741Phase 2Completed
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Yuping Tongqiao Tablet in persistent allergic rhinitis (PAR) (3 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Started Aug 2020; status: completed.
02
Drugs
Yuping Tongqiao Tablet
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on ChiCTR2100042741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042741.